SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ajtj99 who wrote (18046)2/15/2021 3:03:21 PM
From: Sun Tzu1 Recommendation

Recommended By
ajtj99

   of 97559
 
FYI - SCIENCEThe Body Is Far From Helpless Against Coronavirus Variants
The virus is evolving, but the antibodies that fight it can change, too.

KATHERINE J. WUFEBRUARY 12, 2021

...
The large majority of B cells won’t be triggered by the chunks of virus shuttled in during any given infection. But the few that are will begin to rapidly copy themselves in hopes of joining the fray. Some will immediately transform into antibody factories, pumping out gobs of the Y-shaped molecules to run rapid viral interference. Others, however, will remain in the lymph nodes to further study the virus.

Here they will split themselves into more B cells, deliberately introducing errors into their genetic code. If the original genetic scramble created antibodies prepared to take on all manner of pathogens, these random but more subtle tweaks have a chance of enhancing the ability to vanquish the specific virus at hand. The process is a bit like evolution on steroids: Mediocrity gets repeatedly weeded out, leaving only the sharpest and strongest killers behind. By the time a virus has vacated the body, the antibodies being produced against it are, on average, more precise and potent.

Much of this painstaking refinement continues after the virus itself is gone: Certain innate cells will cling to scraps of viral corpses—macabre souvenirs of maladies past—to keep the B cells’ boot camp open in the lymph nodes. In a study published last month in the journal Nature, researchers found that the antibodies of COVID-19 survivors continue to strengthen their grip on the coronavirus for several months.

...

theatlantic.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News